Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective (Q38206496)

31 August 2017

title

Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective (English)

1 reference

31 August 2017

1 reference

cognitive neuroscience

1 reference

Roshan Cools

1 reference

31 August 2017

Trevor W Robbins

0 references

language of work or name

English

0 references

publication date

1 April 2014

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

page(s)

597-607

1 reference

An Essay on the Shaking Palsy

31 August 2017

cites work

1 reference

Memory systems of the brain: a brief history and current perspective

21 January 2018

1 reference

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

21 January 2018

1 reference

Cognitive deficits in the early stages of Parkinson's disease

21 January 2018

1 reference

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

Parkinson's disease. Cognitive changes in relation to treatment response

21 January 2018

1 reference

Internal versus external cues and the control of attention in Parkinson's disease

21 January 2018

1 reference

'Subcortical dementia': the neuropsychological evidence

21 January 2018

1 reference

Remote memory function in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

Temporal ordering and short-term memory deficits in Parkinson's disease

21 January 2018

1 reference

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease

21 January 2018

1 reference

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

Procedural learning and neostriatal dysfunction in man.

21 January 2018

1 reference

The performance on learning tasks of patients in the early stages of Parkinson's disease.

21 January 2018

1 reference

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.

21 January 2018

1 reference

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

21 January 2018

1 reference

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

Visuospatial memory deficits at different stages of Parkinson's disease

21 January 2018

1 reference

Neuropsychological prediction of dementia in Parkinson's disease

21 January 2018

1 reference

Memory and executive function impairment predict dementia in Parkinson's disease

21 January 2018

1 reference

Neuropsychological profile of patients with Parkinson's disease without dementia

21 January 2018

1 reference

Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study

21 January 2018

1 reference

Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.

21 January 2018

1 reference

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

21 January 2018

1 reference

Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease

21 January 2018

1 reference

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

Striatal contributions to working memory: a functional magnetic resonance imaging study in humans

21 January 2018

1 reference

The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease

21 January 2018

1 reference

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

A subcortico-cortical cholinergic system is affected in Parkinson's disease

21 January 2018

1 reference

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

21 January 2018

1 reference

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

21 January 2018

1 reference

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

21 January 2018

1 reference

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition

21 January 2018

1 reference

Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss

21 January 2018

1 reference

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

21 January 2018

1 reference

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease

21 January 2018

1 reference

Getting formal with dopamine and reward

21 January 2018

1 reference

Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions

21 January 2018

1 reference

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

Neuropsychiatric non-motor aspects of Parkinson’s disease

21 January 2018

1 reference

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism

21 January 2018

1 reference

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex

21 January 2018

1 reference

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease

21 January 2018

1 reference

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

21 January 2018

1 reference

A neostriatal habit learning system in humans.

21 January 2018

1 reference

The role of the basal ganglia in learning and memory: Insight from Parkinson’s disease

21 January 2018

1 reference

Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action

21 January 2018

1 reference

Reliance on habits at the expense of goal-directed control following dopamine precursor depletion

21 January 2018

1 reference

Dopamine enhances model-based over model-free choice behavior

21 January 2018

1 reference

Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.

21 January 2018

1 reference

Habitual versus goal-directed action control in Parkinson disease

21 January 2018

1 reference

Motivation, reward, and Parkinson's disease: influence of dopatherapy

21 January 2018

1 reference

Dissociating hippocampal versus basal ganglia contributions to learning and transfer

21 January 2018

1 reference

A neural model of hippocampal-striatal interactions in associative learning and transfer generalization in various neurological and psychiatric patients

21 January 2018

1 reference

A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients

21 January 2018

1 reference

Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease

21 January 2018

1 reference

Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease

21 January 2018

1 reference

Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn?

21 January 2018

1 reference

L-dopa impairs learning, but spares generalization, in Parkinson's disease

21 January 2018

1 reference

Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?

21 January 2018

1 reference

Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients

21 January 2018

1 reference

By carrot or by stick: cognitive reinforcement learning in parkinsonism

21 January 2018

1 reference

Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism

21 January 2018

1 reference

Reversal learning in Parkinson's disease depends on medication status and outcome valence

21 January 2018

1 reference

A role for dopamine in temporal decision making and reward maximization in parkinsonism

21 January 2018

1 reference

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients

21 January 2018

1 reference

Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.

21 January 2018

1 reference

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors

21 January 2018

1 reference

Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task

21 January 2018

1 reference

The debate over dopamine's role in reward: the case for incentive salience

21 January 2018

1 reference

A role for mesencephalic dopamine in activation: commentary on Berridge (2006).

21 January 2018

1 reference

Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens

21 January 2018

1 reference

Apathy blunts neural response to money in Parkinson's disease

21 January 2018

1 reference

Contributions of the ventromedial prefrontal cortex to goal-directed action selection

21 January 2018

1 reference

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

21 January 2018

1 reference

Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease.

21 January 2018

1 reference

Rule-based category learning in patients with Parkinson's disease

21 January 2018

1 reference

The neuropathological basis for depression in Parkinson's disease

21 January 2018

1 reference

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.

21 January 2018

1 reference

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

21 January 2018

1 reference

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

21 January 2018

1 reference

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

21 January 2018

1 reference

A systematic review of prevalence studies of dementia in Parkinson's disease

21 January 2018

1 reference

Neural systems engaged by planning: a PET study of the Tower of London task

21 January 2018

1 reference

Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man.

21 January 2018

1 reference

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

21 January 2018

1 reference

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25853

1 reference

31 August 2017

1 reference